American Medical Technologies Inc. (ADLI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2007 | 2.34 Million USD | -19.47% |
| 2006 | 2.91 Million USD | -0.77% |
| 2005 | 2.94 Million USD | 16.99% |
| 2004 | 2.51 Million USD | -45.13% |
| 2003 | 4.58 Million USD | -25.74% |
| 2002 | 6.16 Million USD | 10.75% |
| 2001 | 5.57 Million USD | 5.31% |
| 2000 | 5.28 Million USD | -36.5% |
| 1999 | 8.32 Million USD | -17.09% |
| 1998 | 10.04 Million USD | 341.99% |
| 1997 | 2.27 Million USD | -49.17% |
| 1996 | 4.47 Million USD | -60.07% |
| 1995 | 11.2 Million USD | 25.84% |
| 1994 | 8.9 Million USD | 2.3% |
| 1993 | 8.7 Million USD | 26.09% |
| 1992 | 6.9 Million USD | 9.52% |
| 1991 | 6.3 Million USD | 40.0% |
| 1990 | 4.5 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2008 Q2 | 2.06 Million USD | -8.18% |
| 2008 Q3 | 1.93 Million USD | -6.22% |
| 2008 Q1 | 2.25 Million USD | -4.23% |
| 2007 Q4 | 2.34 Million USD | -16.45% |
| 2007 Q2 | 3.57 Million USD | -2.59% |
| 2007 FY | 2.34 Million USD | -19.47% |
| 2007 Q1 | 3.67 Million USD | 25.95% |
| 2007 Q3 | 2.81 Million USD | -21.43% |
| 2006 Q2 | 3.32 Million USD | -8.97% |
| 2006 Q3 | 2.96 Million USD | -10.96% |
| 2006 FY | 2.91 Million USD | -0.77% |
| 2006 Q4 | 2.91 Million USD | -1.52% |
| 2006 Q1 | 3.65 Million USD | 24.32% |
| 2005 Q2 | 2.66 Million USD | -2.36% |
| 2005 Q1 | 2.73 Million USD | 8.77% |
| 2005 FY | 2.94 Million USD | 16.99% |
| 2005 Q4 | 2.94 Million USD | 2.55% |
| 2005 Q3 | 2.86 Million USD | 7.41% |
| 2004 Q4 | 2.51 Million USD | -3.5% |
| 2004 Q2 | 2.89 Million USD | -23.49% |
| 2004 Q3 | 2.6 Million USD | -9.93% |
| 2004 Q1 | 3.77 Million USD | -17.49% |
| 2004 FY | 2.51 Million USD | -45.13% |
| 2003 Q1 | 5.87 Million USD | -4.7% |
| 2003 Q3 | 4.13 Million USD | -3.99% |
| 2003 Q4 | 4.58 Million USD | 10.8% |
| 2003 FY | 4.58 Million USD | -25.74% |
| 2003 Q2 | 4.3 Million USD | -26.75% |
| 2002 Q1 | 5.3 Million USD | -4.83% |
| 2002 Q2 | 6.25 Million USD | 18.05% |
| 2002 Q3 | 6.29 Million USD | 0.66% |
| 2002 Q4 | 6.16 Million USD | -2.06% |
| 2002 FY | 6.16 Million USD | 10.75% |
| 2001 Q2 | 3.56 Million USD | -14.82% |
| 2001 Q1 | 4.18 Million USD | -20.86% |
| 2001 Q3 | 4.74 Million USD | 33.21% |
| 2001 Q4 | 5.57 Million USD | 17.27% |
| 2001 FY | 5.57 Million USD | 5.31% |
| 2000 Q4 | 5.28 Million USD | -2.61% |
| 2000 Q1 | 6.36 Million USD | -23.58% |
| 2000 FY | 5.28 Million USD | -36.5% |
| 2000 Q2 | 6.18 Million USD | -2.82% |
| 2000 Q3 | 5.43 Million USD | -12.21% |
| 1999 Q1 | 8.54 Million USD | -14.91% |
| 1999 Q4 | 8.32 Million USD | 8.29% |
| 1999 Q3 | 7.69 Million USD | -13.81% |
| 1999 Q2 | 8.92 Million USD | 4.4% |
| 1999 FY | 8.32 Million USD | -17.09% |
| 1998 Q1 | 3.12 Million USD | 37.65% |
| 1998 FY | 10.04 Million USD | 341.99% |
| 1998 Q4 | 10.04 Million USD | 20.61% |
| 1998 Q3 | 8.32 Million USD | 209.34% |
| 1998 Q2 | 2.69 Million USD | -13.94% |
| 1997 Q3 | 2.94 Million USD | -8.21% |
| 1997 FY | 2.27 Million USD | -49.17% |
| 1997 Q4 | 2.27 Million USD | -22.77% |
| 1997 Q2 | 3.2 Million USD | -32.24% |
| 1997 Q1 | 4.73 Million USD | 5.8% |
| 1996 Q3 | 7.57 Million USD | -27.75% |
| 1996 Q4 | 4.47 Million USD | -40.97% |
| 1996 FY | 4.47 Million USD | -60.07% |
| 1996 Q2 | 10.48 Million USD | -2.92% |
| 1996 Q1 | 10.8 Million USD | -3.57% |
| 1995 FY | 11.2 Million USD | 25.84% |
| 1995 Q4 | 11.2 Million USD | 10.89% |
| 1995 Q1 | 9.5 Million USD | 6.74% |
| 1995 Q2 | 8.6 Million USD | -9.47% |
| 1995 Q3 | 10.1 Million USD | 17.44% |
| 1994 Q4 | 8.9 Million USD | 7.23% |
| 1994 Q2 | 8.5 Million USD | -4.49% |
| 1994 Q1 | 8.9 Million USD | 2.3% |
| 1994 Q3 | 8.3 Million USD | -2.35% |
| 1994 FY | 8.9 Million USD | 2.3% |
| 1993 Q4 | 8.7 Million USD | 1.16% |
| 1993 FY | 8.7 Million USD | 26.09% |
| 1993 Q1 | 6.5 Million USD | -5.8% |
| 1993 Q2 | 8.5 Million USD | 30.77% |
| 1993 Q3 | 8.6 Million USD | 1.18% |
| 1992 Q2 | 4.8 Million USD | 54.84% |
| 1992 Q3 | 3.5 Million USD | -27.08% |
| 1992 Q4 | 6.9 Million USD | 97.14% |
| 1992 FY | 6.9 Million USD | 9.52% |
| 1992 Q1 | 3.1 Million USD | -50.79% |
| 1991 FY | 6.3 Million USD | 40.0% |
| 1991 Q1 | 7.9 Million USD | 75.56% |
| 1991 Q2 | 5.3 Million USD | -32.91% |
| 1991 Q4 | 6.3 Million USD | 16.67% |
| 1991 Q3 | 5.4 Million USD | 1.89% |
| 1990 Q4 | 4.5 Million USD | 0.0% |
| 1990 FY | 4.5 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ansell Limited | 1.32 Billion USD | 99.823% |
| Ansell Limited | 1.33 Billion USD | 99.824% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 98.14% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -149.143% |
| Psykey, Inc. | 2.47 Million USD | 5.019% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.884% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.884% |
| Encision Inc. | 1.98 Million USD | -18.442% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 22.715% |
| Innovative MedTech Inc. | 6.13 Million USD | 61.697% |
| LifePoint, Inc. | 2.45 Million USD | 4.251% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 76.919% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 30.887% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 22.711% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -202.687% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.761% |
| Sector 10, Inc. | 9.84 Million USD | 76.133% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.827% |
| SheerVision, Inc. | 1.43 Million USD | -64.164% |
| United Health Products, Inc. | 1.99 Million USD | -17.559% |
| Vasamed, Inc. | 1 Million USD | -133.746% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 38.167% |
| Yubo International Biotech Limited | 2.91 Million USD | 19.358% |